Briumvi Interactions
There are 402 drugs known to interact with Briumvi (ublituximab), along with 3 disease interactions. Of the total drug interactions, 301 are major, 94 are moderate, and 7 are minor.
- View all 402 medications that may interact with Briumvi
- View Briumvi disease interactions (3)
Most frequently checked interactions
View interaction reports for Briumvi (ublituximab) and the medicines listed below.
- Abilify (aripiprazole)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- amantadine
- ambrisentan
- amitriptyline
- Amondys 45 (casimersen)
- Ampyra (dalfampridine)
- apremilast
- atorvastatin
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- B-12 (cyanocobalamin)
- baclofen
- Bactrim (sulfamethoxazole / trimethoprim)
- Bafiertam (monomethyl fumarate)
- Benicar HCT (hydrochlorothiazide / olmesartan)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Emgality (galcanezumab)
- Klonopin (clonazepam)
- Ocrevus (ocrelizumab)
- oxycodone
- tizanidine
- topiramate
- Vitamin D3 (cholecalciferol)
Briumvi disease interactions
There are 3 disease interactions with Briumvi (ublituximab) which include:
More about Briumvi (ublituximab)
- Briumvi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.